March 26, 2025
Today, the Alliance for Clinical Trials in Oncology was informed that the U.S. Food and Drug Administration has approved cabozantinib for the treatment of patients with previously treated advanced neuroendocrine tumors (NETs). NETs are a type of cancer that manifest characteristics of both nerve and hormone-producing cells, and can arise in
March 24, 2025
Five important clinical trials focused on innovative treatments for colorectal and bladder cancer are spotlighted in observance of National Colorectal Cancer Awareness Month. These trials aim to improve outcomes and advance cancer care.
February 21, 2025
Dear Colleagues and Friends, The Cooperative Groups that come together in the National Clinical Trials Network (NCTN) are responsible for a number of significant advances in cancer treatment arising over the past 40 years. In that time, as published by Unger et al (J Clin Oncol, 2023), this research has led to an estimated 14 million life-years saved for patients with cancer,